Neuroimmune Mechanisms of Glucocorticoid Resistance
糖皮质激素抵抗的神经免疫机制
基本信息
- 批准号:7406095
- 负责人:
- 金额:$ 19.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-05 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:Antisense OligonucleotidesAutoimmune ProcessAutopsyBehaviorBehavioralBindingBiochemicalBiologicalBiological AssayBiological ModelsCell LineCellsChronicChronic stressCompanionsControl GroupsCorticotropin-Releasing HormoneCyclic AMPCyclic AMP-Dependent Protein KinasesCytokine SignalingDNADNA BindingDataDepressed moodDevelopmentDiseaseElectrophoretic Mobility Shift AssayEnzyme-Linked Immunosorbent AssayEventExhibitsExposure toFeedbackFibroblastsFunctional disorderGliomaGlucocorticoid ReceptorGlucocorticoidsHepatitis CHippocampus (Brain)Hyperactive behaviorImmune responseImmune systemImpairmentIn VitroInflammationInflammatoryInterferon-alphaInterferonsInterleukin-1Interleukin-1 alphaLeadLeftLigand BindingLuciferasesMAP Kinase GeneMAPK14 geneMAPK8 geneMajor Depressive DisorderMeasuresMediatingMediator of activation proteinMedicalMental DepressionMitogen-Activated Protein KinasesModelingMolecularMood DisordersMoodsMusNF-kappa BNFKB Signaling PathwayNeuroimmunomodulationNeuronsNeurosecretory SystemsNuclearNuclear TranslocationNumbersPC12 CellsPTGS2 genePathway interactionsPatientsPeripheral Blood Mononuclear CellPersonal SatisfactionPheochromocytomaPhosphorylationPlayPolymerase Chain ReactionProstaglandin-Endoperoxide SynthaseRattusReceptor SignalingRegulationResearchResearch PersonnelResistanceRoleSTAT5A geneSamplingSecondary toSeriesSignal PathwaySignal TransductionSignal Transduction PathwaySignaling MoleculeSkinSympathetic Nervous SystemTechniquesTestingTherapeuticTimeTransfectionWestern BlottingWorkbrain tissuecelecoxibcyclooxygenase 1cyclooxygenase 2cytokinedesigndisturbance in affectenvironmental stressorglucocorticoid-induced orphan receptorin vivoinhibitor/antagonistneuropsychiatrynovelprogramsprotein protein interactionreceptor expressionreceptor functionresearch studyresponsetranscription factor
项目摘要
DESCRIPTION (provided by applicant): A number of illnesses including autoimmune, infectious and inflammatory disorders as well as certain neuropsychiatric disorders such as major depression have been associated with decreased responsiveness to glucocorticoids. Impaired responsiveness to glucocorticpids in turn is believed to contribute to excessive inflammation as well as hyperactivity of corticotropin releasing hormone (CRH) and sympathetic nervous system pathways, which may contribute to behavioral alterations. The primary hypothesis of this proposal is that chronic exposure to proinflammatory cytokines as may occur in the context of chronic medical illness and/or chronic stress leads to impaired glucocorticoid responsiveness through direct effects on the glucocorticoid receptor (GR). The long-term objectives of the proposed work are to determine the molecular mechanisms by which cytokines influence GR signaling and to identify specific signaling molecules/pathways that may be targeted to reverse cytokine-induced GR changes. In this project, the following specific aims are proposed: 1) to determine the signal transduction pathways that mediate the effects of proinflammatory cytokines and other immunoregulatory cytokines on GR function, 2) to determine the interaction of PKA and proinflammatory signaling pathways in the regulation of GR, and 3) to investigate the relationship between intracellular p38, JNK, STAT, and NF-kB signaling pathways and PKA signaling pathways as they relate to GR signaling, neuroendocrine function and mood in patients treated with IFN-a for hepatitis C. To accomplish these aims, a series of in vitro studies (Aims 1 and 2) will be conducted on cell lines and primary cells, examining the impact of IL-1-and IFN-alpha-induced signal transduction events (including activation of p38, JNK, and STAT as well as NF-kB and COX signaling pathways) on GR function. In Aim 2, these studies will be expanded to examine the interaction of PKA signaling pathways with IL-1-and IFN-alpha-induced signaling pathways using PKA deficient cell lines and primary cells (fibroblasts) from depressed patients with reduced PKA activity. Finally, in Aim 3, 30 patients with hepatitis C will be assessed before and during IFN-alpha treatment and compared to 15 hepatitis C patients awaiting IFN therapy. IFN-alpha is a potent activator of proinflammatory cytokines and is notorious for inducing mood alterations. Peripheral blood mononuclear cells will be obtained from IFN-alpha-treated patients for the assessment of p38, JNK, and STAT as well as NF-kB, STAT, COX-2 and PKA signaling. Results will be correlated with data being collected in a companion study examining mood and in vivo measures of glucocorticoid responsiveness (Dex-CRH test). Taken together, these studies will help identify novel targets for the treatment of mood disorders in both medically ill and medically healthy patients.
描述(由申请人提供):许多疾病,包括自身免疫性疾病、感染性疾病和炎症性疾病以及某些神经精神疾病(例如重度抑郁症)与糖皮质激素反应性降低有关。人们认为,对糖皮质激素的反应性受损反过来会导致过度炎症以及促肾上腺皮质激素释放激素(CRH)和交感神经系统通路的过度活跃,这可能会导致行为改变。该提议的主要假设是,在慢性疾病和/或慢性压力的情况下,长期接触促炎细胞因子可能会通过对糖皮质激素受体(GR)的直接影响而导致糖皮质激素反应性受损。拟议工作的长期目标是确定细胞因子影响 GR 信号传导的分子机制,并确定可逆转细胞因子诱导的 GR 变化的特定信号分子/途径。在该项目中,提出了以下具体目标:1)确定介导促炎细胞因子和其他免疫调节细胞因子对GR功能影响的信号转导途径,2)确定PKA和促炎信号传导途径在调节GR功能中的相互作用。 GR,3) 研究细胞内 p38、JNK、STAT 和 NF-kB 信号通路与 PKA 信号通路之间的关系,因为它们与 GR 信号传导、神经内分泌相关使用 IFN-a 治疗丙型肝炎的患者的功能和情绪。为了实现这些目标,将对细胞系和原代细胞进行一系列体外研究(目标 1 和 2),检查 IL-1-和IFN-α 诱导的 GR 功能信号转导事件(包括 p38、JNK 和 STAT 以及 NF-kB 和 COX 信号通路的激活)。在目标 2 中,这些研究将扩大到使用 PKA 缺陷细胞系和来自 PKA 活性降低的抑郁症患者的原代细胞(成纤维细胞)来检查 PKA 信号通路与 IL-1 和 IFN-α 诱导的信号通路的相互作用。最后,在目标 3 中,将在 IFN-α 治疗之前和治疗期间对 30 名丙型肝炎患者进行评估,并与等待 IFN 治疗的 15 名丙型肝炎患者进行比较。 IFN-α 是促炎细胞因子的有效激活剂,因诱导情绪改变而臭名昭著。从接受 IFN-α 治疗的患者中获取外周血单核细胞,用于评估 p38、JNK 和 STAT 以及 NF-kB、STAT、COX-2 和 PKA 信号转导。结果将与检查情绪和体内糖皮质激素反应性测量(Dex-CRH 测试)的同伴研究中收集的数据相关联。总而言之,这些研究将有助于确定治疗患病和健康患者情绪障碍的新靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW H MILLER其他文献
ANDREW H MILLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW H MILLER', 18)}}的其他基金
Using Human iPSC Models to Determine the Mechanism of Inflammation-Induced Disruption of Dopamine Neurotransmission
使用人类 iPSC 模型确定炎症引起的多巴胺神经传递中断的机制
- 批准号:
10575155 - 财政年份:2022
- 资助金额:
$ 19.61万 - 项目类别:
Using Human iPSC Models to Determine the Mechanism of Inflammation-Induced Disruption of Dopamine Neurotransmission
使用人类 iPSC 模型确定炎症引起的多巴胺神经传递中断的机制
- 批准号:
10707196 - 财政年份:2022
- 资助金额:
$ 19.61万 - 项目类别:
Emory Psychiatry Clinical Scientist Training Program (CSTP)
埃默里精神病学临床科学家培训计划 (CSTP)
- 批准号:
8894612 - 财政年份:2014
- 资助金额:
$ 19.61万 - 项目类别:
Emory Psychiatry Clinical Scientist Training Program (CSTP)
埃默里精神病学临床科学家培训计划 (CSTP)
- 批准号:
8751923 - 财政年份:2014
- 资助金额:
$ 19.61万 - 项目类别:
Inflammation-Induced CNS Glutamate During Breast Cancer Treatment
乳腺癌治疗期间炎症诱导的中枢神经系统谷氨酸
- 批准号:
8815732 - 财政年份:2014
- 资助金额:
$ 19.61万 - 项目类别:
Predictors and Targets of Response to Cytokine Antagonism in Depression
抑郁症细胞因子拮抗反应的预测因素和目标
- 批准号:
8489793 - 财政年份:2013
- 资助金额:
$ 19.61万 - 项目类别:
Predictors and Targets of Response to Cytokine Antagonism in Depression
抑郁症细胞因子拮抗反应的预测因素和目标
- 批准号:
8641432 - 财政年份:2013
- 资助金额:
$ 19.61万 - 项目类别:
Phenotyping Major Depression with Increased Inflammation
炎症加剧的重度抑郁症表型分析
- 批准号:
7986778 - 财政年份:2010
- 资助金额:
$ 19.61万 - 项目类别:
Phenotyping Major Depression with Increased Inflammation
炎症加剧的重度抑郁症表型分析
- 批准号:
8438483 - 财政年份:2010
- 资助金额:
$ 19.61万 - 项目类别:
Phenotyping Major Depression with Increased Inflammation
炎症加剧的重度抑郁症表型分析
- 批准号:
8098152 - 财政年份:2010
- 资助金额:
$ 19.61万 - 项目类别:
相似国自然基金
Setd2通过调控糖酵解过程促进树突状细胞活化启动1型糖尿病自身免疫应答的机制研究
- 批准号:82300929
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于动态对比增强联合分子靶向MRI可视化自身免疫性周围神经损伤及修复过程的实验研究
- 批准号:82302173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α-心脏肌球蛋白重链特异性T细胞在自身免疫性心肌炎致病过程中的作用及机制探讨
- 批准号:82000470
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
LC3相关的吞噬作用(LAP)对矽肺发展过程中矽尘诱发自身免疫性疾病的作用机制研究
- 批准号:81773376
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
自身免疫性胆管炎发病过程中NK细胞的免疫调节作用
- 批准号:81401336
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Neurodegeneration Underlying Distinct Disabilities in Multiple Sclerosis Using a Cell-Specific, Region-Specific, and Sex-Specific Approach
使用细胞特异性、区域特异性和性别特异性方法研究多发性硬化症中明显残疾的神经退行性变
- 批准号:
10663020 - 财政年份:2023
- 资助金额:
$ 19.61万 - 项目类别:
Targeting Cholesterol Homeostasis to maintain vision in MS-like optic neuritis
针对多发性硬化症样视神经炎的胆固醇稳态以维持视力
- 批准号:
10657163 - 财政年份:2023
- 资助金额:
$ 19.61万 - 项目类别:
Anti-interneuron antibodies in rapid-onset pediatric OCD: clinical generalization and target identification
快速发作的儿科强迫症中的抗中间神经元抗体:临床概括和靶标识别
- 批准号:
10530955 - 财政年份:2022
- 资助金额:
$ 19.61万 - 项目类别:
Neuroinflammation in Cerebral Small Vessel Disease using PET/MR Imaging
使用 PET/MR 成像研究脑小血管疾病的神经炎症
- 批准号:
10467487 - 财政年份:2022
- 资助金额:
$ 19.61万 - 项目类别: